tiprankstipranks
Trending News
More News >
Cannomed Medical Cannabis Industries Ltd. (IL:GEFR)
:GEFR
Israel Market

Cannomed (GEFR) Income Statement

Compare
0 Followers

Cannomed Income Statement

Last quarter (Q4 2024), Cannomed's total revenue was 25.00K, a decrease of -29.58% from the same quarter last year. In Q4, Cannomed's net income was -1.33M. See Cannomed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
131.00K 142.00K 60.00K 658.00K 17.92M
Gross Profit
131.00K 142.00K -5.93M -10.22M 4.83M
Operating Expenses
6.33M 6.92M 4.32M 5.45M 9.92M
Depreciation and Amortization
339.00K 518.00K 2.14M 1.96M 605.00K
EBITDA
-5.58M -6.11M -16.48M -18.18M -5.29M
Operating Income
-6.20M -6.78M -18.88M -20.16M -9.60M
Other Income/Expenses
0.00 111.00K -146.00K -894.00K -1.41M
Pretax Income
-6.20M -6.67M -19.02M -21.05M -11.15M
Net Income
-5.07M -6.91M -20.08M -13.43M -8.81M
Per Share Metrics
Basic EPS
-0.02 -0.03 -0.20 -0.15 -0.35
Diluted EPS
-0.02 -0.03 -0.20 -0.15 -0.35
Weighted Average Shares Outstanding
256.25M 251.19M 99.39M 88.04M 24.93M
Weighted Average Shares Outstanding (Diluted)
256.25M 215.64M 99.39M 88.04M 24.93M
Currency in ILS

Cannomed Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis